SavedAdd your journal

Journals / Eurasian Journal of Health Technology Assessment / 2020 / Cilt: 4 - Sayı: 1

Ocular Findings of COVID-19

COVID-19'un Oküler Bulguları

Esra DAĞ ŞEKER
Pages
1–8
Publication Date
2020-11-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

All these findings coulddenote that COVID-19 is a systemic disease with ongoing effects and can request long term follow up.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The new Corona Virus Disease (COVID-19) which is caused by the SARS– CoV-2 agent and first reported in December2019, has the potential to damage many tissues and organs, since the angiotensin converting enzyme (ACE), which theagent attaches, is expressed widely in the human body.
📊
Key Findings & Data:As the pandemic period continues, the scientific publishespointing ocular involvement have been increased.
💡
Conclusion & Impact:All these findings coulddenote that COVID-19 is a systemic disease with ongoing effects and can request long term follow up.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:COVID-19 · SARS-CoV-2 · Göz

Abstract

The new Corona Virus Disease (COVID-19) which is caused by the SARS– CoV-2 agent and first reported in December2019, has the potential to damage many tissues and organs, since the angiotensin converting enzyme (ACE), which theagent attaches, is expressed widely in the human body. As the pandemic period continues, the scientific publishespointing ocular involvement have been increased. Ocular involvement can be in different clinical presentations. The aimof this study is to overview the ocular involvement, complications with pathophysiology of COVID-19. In this study asearch from Pubmed database is carried out,, the articles including ocular findings of COVID-19 between January 2020-October 2020, are evaluated.. The studies report that the disease presents with conjunctivitis at the acute phase, sincemicrovascular, thrombotic, ischemic and inflammatory lesions are evident in the ongoing period. All these findings coulddenote that COVID-19 is a systemic disease with ongoing effects and can request long term follow up.

Özet

Aralık 2019’da bildirilen, SARS CoV-2 etkeninin sebep olduğu yeni tip Korona virüs hastalığı (COVID-19), etkenintutunduğu Anjiotensin Dönüştürücü Enzimin (ACE) tüm vücutta yaygın olarak bulunması sebebiyle, bir çok doku veorganı etkileyebilmektedir. Pand emi süreci ilerledikçe oküler tutulumu gösteren yayınlar artmaktadır. Oküler tutulumfarklı klinik prezentasyonlarla olabilmektedir. Bu çalışmanın amacı COVID-19’un oküler tutulum ve komplikasyonlarıpatofizyolojisi ile gözden geçirmektir. Çalışmada Pubmed veri tabanı üzerinden Ocak 2020-Ekim 2020 dönemindeCOVID-19’un göz bulgularını içeren makaleler taranarak bulgular değerlendirildi. Yapılan çalışmalarda hastalığın gözdeakut dönemde konjonktivit ve ön segment tutulumu ile presente olabilirken, sonraki süreçte ise mikrovasküler, trombotik,iskemik ve inflamatuar lezyonlar ile arka segment tutulumu ön planda bildirilmektedir. Tüm bu bulgular COVID-19’unuzun dönem etkileri olabilen ve uzun dönem takip gerektiren sistemik bir hastalık olduğunu düşündürmektedir.

🔖

Cite This Article

ŞEKER, E. D. (2020). Ocular Findings of COVID-19. Eurasian Journal of Health Technology Assessment, Cilt: 4 - Sayı: 1, 1–8. https://ajindex.com/articles/756314

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Acharya, S., Diamond, M., Anwar, S., Glaser, A., Tyagi, P. (2020) Unique case of central retinal artery occlusion secondary to COVID-19 disease. ID Cases, 21:00867. 10.1016/j.idcr.2020.e00867. Ackermann, M., Verleden, S., E., Kuehnel, M. (2020). Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med., 383(2):122–128.
  2. Agarwal, A., Invernizzi, A., Acquistapace, A. (2017). Analysis of retinochoroidal vasculature in human immunodeficiency virus infection using spectral-domain OCT angiography. Ophthalmol Retina, 1(6):545–554.
  3. Bart, K., Chwalisz, M.D., Marc, J., Dinkin, M.D. (2020) Disease of the Year: COVID-19 and Its Neuro-ophthalmic Complications. J. Neuroophthalmol., doi: 10.1097/WNO.0000000000001046. Bertoli, F., Veritti, D., Danese, C., Samassa, F., Sarao, V., Rassu, N.,…Lanzetta, P. (2020) Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye. J Ophthalmol., doi: 10.1155/2020/4827304. Bogoch, I., Watts, A., Thomas-Bachli, A., Huber, C., Kraemer, M.U.G., Khan, K. (2020). Pneumonia of unknown etiology in Wuhan, China: potential for international spread via commercial air travel. J. Trav. Med, 27: DOI:10.1093/jtm/taaa008/570. Casagrande, M., Fitzek, A., Püschel, K., Aleshcheva, G., Schultheiss, H., P., Berneking, L., Spitzer, M., S., Schultheiss, M. (2020). Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm, 28:721–5.
  4. Chen, L., Deng, C., Chen, X., Zhang, X., Chen, B., Yu, H., Qin, Y. (2020). Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol, 10.1111:14472. Du Toit, A. (2020). Outbreak of a novel coronavirus. Nat. Rev. Microbiol, 18(123). Gavriilaki, E., Brodsky, R., A. (2020). Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily. British Journal of Haematology, 189(6):227-230. Gutiérrez-Ortiz, C., Méndez- Guerrero A., Rodrigo-Rey, S., San Pedro- Murillo, E., Bermejo Guerrero, L., Gordo-Manas, R.,…Benito-Leon, J. (2020) Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology, 95(5):601-605.
  5. Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X.,…Meziani,F. (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intens Care Med., 46:1089-1098. Insausti-García, A., Reche-Sainz, J.A., Ruiz-Arranz, C., Lópe